25 XP   0   0   10

Cannabics Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Cannabics Pharmaceuticals Inc together

PenkeI guess you are interested in Cannabics Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cannabics Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cannabics Pharmaceuticals Inc

I send you an email if I find something interesting about Cannabics Pharmaceuticals Inc.

Quick analysis of Cannabics Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Cannabics Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.08
Expected worth in 1 year
$-0.09
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-85.8%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0.01 - $0.02
How sure are you?
50%

1. Valuation of Cannabics Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$0.01

Intrinsic Value Per Share

$-0.05 - $-0.06

Total Value Per Share

$-0.13 - $-0.13

2. Growth of Cannabics Pharmaceuticals Inc (5 min.)




Is Cannabics Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.3m-$1.7m-$394.8k-18.8%

How much money is Cannabics Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$308k-$1m$727.7k236.2%
Net Profit Margin-406.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Cannabics Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#902 / 1010

Most Revenue
#618 / 1010

Most Profit
#190 / 1010

Most Efficient
#712 / 1010

What can you expect buying and holding a share of Cannabics Pharmaceuticals Inc? (5 min.)

Welcome investor! Cannabics Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Cannabics Pharmaceuticals Inc.

What can you expect buying and holding a share of Cannabics Pharmaceuticals Inc?

First you should know what it really means to hold a share of Cannabics Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Cannabics Pharmaceuticals Inc is $0.013. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cannabics Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cannabics Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.08. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cannabics Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-80.5%-0.01-76.2%-0.01-103.5%-0.01-96.6%-0.01-58.3%
Usd Book Value Change Per Share-0.01-65.2%0.00-21.4%-0.02-116.0%-0.03-251.3%0.00-14.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-65.2%0.00-21.4%-0.02-116.0%-0.03-251.3%0.00-14.3%
Usd Price Per Share0.01-0.02-3.12-0.76-0.73-
Price to Earnings Ratio-0.24--0.49--50.83--15.35--35.83-
Price-to-Total Gains Ratio-1.18--1.22--206.86--48.50--0.11-
Price to Book Ratio-0.13--0.23--65.08--6.87--67.84-
Price-to-Total Gains Ratio-1.18--1.22--206.86--48.50--0.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.013
Number of shares76923
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.03
Usd Total Gains Per Share0.00-0.03
Gains per Quarter (76923 shares)-214.49-2,512.87
Gains per Year (76923 shares)-857.97-10,051.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-858-8680-10051-10061
20-1716-17260-20103-20112
30-2574-25840-30154-30163
40-3432-34420-40206-40214
50-4290-43000-50257-50265
60-5148-51580-60309-60316
70-6006-60160-70360-70367
80-6864-68740-80412-80418
90-7722-77320-90463-90469
100-8580-85900-100515-100520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.028.011.02.5%1.028.012.02.4%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%4.016.00.020.0%14.026.00.035.0%14.027.00.034.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.041.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%4.016.00.020.0%14.026.00.035.0%14.027.00.034.1%

Fundamentals of Cannabics Pharmaceuticals Inc

About Cannabics Pharmaceuticals Inc

CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. The company is a subsidiary of Cannabics Inc.

Fundamental data was last updated by Penke on 2024-04-20 22:34:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cannabics Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cannabics Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cannabics Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -800.9% means that $-8.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is -800.9%. The company is making a huge loss. -2
  • The TTM is -406.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-800.9%TTM-406.0%-394.9%
TTM-406.0%YOY--406.0%
TTM-406.0%5Y-26,286.0%+25,880.0%
5Y-26,286.0%10Y-16,014.4%-10,271.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-800.9%-207.2%-593.7%
TTM-406.0%-216.8%-189.2%
YOY--282.3%+282.3%
5Y-26,286.0%-436.8%-25,849.2%
10Y-16,014.4%-597.3%-15,417.1%
1.1.2. Return on Assets

Shows how efficient Cannabics Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cannabics Pharmaceuticals Inc to the Biotechnology industry mean.
  • -198.6% Return on Assets means that Cannabics Pharmaceuticals Inc generated $-1.99 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is -198.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -95.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-198.6%TTM-95.7%-102.8%
TTM-95.7%YOY-189.1%+93.4%
TTM-95.7%5Y-78.9%-16.8%
5Y-78.9%10Y-44.7%-34.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-198.6%-13.3%-185.3%
TTM-95.7%-12.8%-82.9%
YOY-189.1%-11.6%-177.5%
5Y-78.9%-13.8%-65.1%
10Y-44.7%-15.6%-29.1%
1.1.3. Return on Equity

Shows how efficient Cannabics Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cannabics Pharmaceuticals Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Cannabics Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-27.6%+27.6%
5Y-27.6%10Y-18.0%-9.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY--14.9%+14.9%
5Y-27.6%-19.3%-8.3%
10Y-18.0%-20.1%+2.1%

1.2. Operating Efficiency of Cannabics Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cannabics Pharmaceuticals Inc is operating .

  • Measures how much profit Cannabics Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cannabics Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-14.0%+14.0%
TTM-14.0%YOY--14.0%
TTM-14.0%5Y-1,612.7%+1,598.7%
5Y-1,612.7%10Y-8,201.4%+6,588.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM-14.0%-238.5%+224.5%
YOY--288.4%+288.4%
5Y-1,612.7%-486.2%-1,126.5%
10Y-8,201.4%-628.4%-7,573.0%
1.2.2. Operating Ratio

Measures how efficient Cannabics Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 6.23 means that the operating costs are $6.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is 6.233. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.332. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.233TTM3.332+2.901
TTM3.332YOY-+3.332
TTM3.3325Y132.640-129.308
5Y132.64010Y137.289-4.649
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2333.235+2.998
TTM3.3323.310+0.022
YOY-3.838-3.838
5Y132.6405.679+126.961
10Y137.2897.823+129.466

1.3. Liquidity of Cannabics Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cannabics Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.06 means the company has $0.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is 0.065. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.088. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.065TTM0.088-0.023
TTM0.088YOY0.068+0.019
TTM0.0885Y2.283-2.195
5Y2.28310Y2.722-0.439
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0653.863-3.798
TTM0.0884.169-4.081
YOY0.0685.337-5.269
5Y2.2836.122-3.839
10Y2.7226.434-3.712
1.3.2. Quick Ratio

Measures if Cannabics Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cannabics Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.496-1.496
5Y1.49610Y0.811+0.684
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.504-3.504
TTM-3.991-3.991
YOY-5.371-5.371
5Y1.4966.088-4.592
10Y0.8116.395-5.584

1.4. Solvency of Cannabics Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cannabics Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cannabics Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 15.39 means that Cannabics Pharmaceuticals Inc assets are financed with 1,538.9% credit (debt) and the remaining percentage (100% - 1,538.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is 15.389. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 7.681. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ15.389TTM7.681+7.708
TTM7.681YOY3.707+3.973
TTM7.6815Y2.482+5.198
5Y2.48210Y3.154-0.671
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.3890.339+15.050
TTM7.6810.337+7.344
YOY3.7070.271+3.436
5Y2.4820.368+2.114
10Y3.1540.388+2.766
1.4.2. Debt to Equity Ratio

Measures if Cannabics Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cannabics Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cannabics Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.249-0.249
5Y0.24910Y7.799-7.550
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.403-0.403
YOY-0.335-0.335
5Y0.2490.427-0.178
10Y7.7990.461+7.338

2. Market Valuation of Cannabics Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cannabics Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Cannabics Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -0.24 means the investor is paying $-0.24 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cannabics Pharmaceuticals Inc:

  • The EOD is -0.311. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.239. Based on the earnings, the company is expensive. -2
  • The TTM is -0.488. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.311MRQ-0.239-0.072
MRQ-0.239TTM-0.488+0.249
TTM-0.488YOY-50.830+50.342
TTM-0.4885Y-15.352+14.864
5Y-15.35210Y-35.834+20.482
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.311-2.300+1.989
MRQ-0.239-2.656+2.417
TTM-0.488-2.718+2.230
YOY-50.830-4.145-46.685
5Y-15.352-6.258-9.094
10Y-35.834-6.315-29.519
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cannabics Pharmaceuticals Inc:

  • The EOD is -0.813. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.625. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.619. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.813MRQ-0.625-0.188
MRQ-0.625TTM-0.619-0.006
TTM-0.619YOY-160.557+159.938
TTM-0.6195Y-38.271+37.652
5Y-38.27110Y-64.016+25.746
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.813-2.974+2.161
MRQ-0.625-3.306+2.681
TTM-0.619-3.508+2.889
YOY-160.557-5.613-154.944
5Y-38.271-8.378-29.893
10Y-64.016-8.873-55.143
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cannabics Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.13 means the investor is paying $-0.13 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cannabics Pharmaceuticals Inc:

  • The EOD is -0.171. Based on the equity, the company is expensive. -2
  • The MRQ is -0.132. Based on the equity, the company is expensive. -2
  • The TTM is -0.229. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.171MRQ-0.132-0.040
MRQ-0.132TTM-0.229+0.097
TTM-0.229YOY-65.076+64.847
TTM-0.2295Y-6.871+6.642
5Y-6.87110Y-67.842+60.971
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1711.914-2.085
MRQ-0.1322.116-2.248
TTM-0.2292.097-2.326
YOY-65.0762.881-67.957
5Y-6.8713.550-10.421
10Y-67.8423.936-71.778
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cannabics Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.008-0.003-67%-0.015+78%-0.033+286%-0.002-78%
Book Value Per Share---0.076-0.067-11%-0.055-28%0.040-292%0.051-249%
Current Ratio--0.0650.088-26%0.068-5%2.283-97%2.722-98%
Debt To Asset Ratio--15.3897.681+100%3.707+315%2.482+520%3.154+388%
Debt To Equity Ratio----0%-0%0.249-100%7.799-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.010-0.010-5%-0.013+29%-0.013+20%-0.008-28%
Free Cash Flow Per Share---0.004-0.002-61%-0.005+29%-0.007+64%-0.010+147%
Free Cash Flow To Equity Per Share---0.004-0.001-82%-0.002-54%-0.003-19%0.012-133%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.725+38%
Intrinsic Value_10Y_max---0.056--------
Intrinsic Value_10Y_min---0.052--------
Intrinsic Value_1Y_max---0.013--------
Intrinsic Value_1Y_min---0.013--------
Intrinsic Value_3Y_max---0.034--------
Intrinsic Value_3Y_min---0.032--------
Intrinsic Value_5Y_max---0.047--------
Intrinsic Value_5Y_min---0.044--------
Market Cap404448.200+23%311114.000466671.000-33%96912011.000-100%35470218.536-99%28410519.507-99%
Net Profit Margin---8.009-4.060-49%--100%-262.860+3182%-160.144+1900%
Operating Margin----0.1400%-0%-16.1270%-82.0140%
Operating Ratio--6.2333.332+87%-+100%132.640-95%137.289-95%
Pb Ratio-0.171-30%-0.132-0.229+73%-65.076+49233%-6.871+5109%-67.842+51330%
Pe Ratio-0.311-30%-0.239-0.488+104%-50.830+21169%-15.352+6324%-35.834+14894%
Price Per Share0.013+23%0.0100.015-33%3.115-100%0.764-99%0.725-99%
Price To Free Cash Flow Ratio-0.813-30%-0.625-0.619-1%-160.557+25579%-38.271+6021%-64.016+10139%
Price To Total Gains Ratio-1.534-30%-1.180-1.215+3%-206.864+17427%-48.504+4010%-0.105-91%
Quick Ratio----0%-0%1.496-100%0.811-100%
Return On Assets---1.986-0.957-52%-1.891-5%-0.789-60%-0.447-77%
Return On Equity----0%-0%-0.2760%-0.1800%
Total Gains Per Share---0.008-0.003-67%-0.015+78%-0.033+286%-0.002-78%
Usd Book Value---2358534.000-2095048.500-11%-1700157.000-28%2203601.950-207%2069810.555-214%
Usd Book Value Change Per Share---0.008-0.003-67%-0.015+78%-0.033+286%-0.002-78%
Usd Book Value Per Share---0.076-0.067-11%-0.055-28%0.040-292%0.051-249%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.010-0.010-5%-0.013+29%-0.013+20%-0.008-28%
Usd Free Cash Flow---124398.000-48878.500-61%-160115.000+29%-456149.300+267%-348603.746+180%
Usd Free Cash Flow Per Share---0.004-0.002-61%-0.005+29%-0.007+64%-0.010+147%
Usd Free Cash Flow To Equity Per Share---0.004-0.001-82%-0.002-54%-0.003-19%0.012-133%
Usd Market Cap404448.200+23%311114.000466671.000-33%96912011.000-100%35470218.536-99%28410519.507-99%
Usd Price Per Share0.013+23%0.0100.015-33%3.115-100%0.764-99%0.725-99%
Usd Profit---325459.000-308056.500-5%-1035837.250+218%-1027004.800+216%-554152.154+70%
Usd Revenue--40637.000135059.750-70%-+100%27580.700+47%17080.554+138%
Usd Total Gains Per Share---0.008-0.003-67%-0.015+78%-0.033+286%-0.002-78%
 EOD+6 -2MRQTTM+3 -26YOY+13 -165Y+16 -1510Y+10 -22

3.2. Fundamental Score

Let's check the fundamental score of Cannabics Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.311
Price to Book Ratio (EOD)Between0-1-0.171
Net Profit Margin (MRQ)Greater than0-8.009
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.065
Debt to Asset Ratio (MRQ)Less than115.389
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.986
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Cannabics Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.204
Ma 20Greater thanMa 500.011
Ma 50Greater thanMa 1000.012
Ma 100Greater thanMa 2000.013
OpenGreater thanClose0.013
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-02-29. Currency in USD. All numbers in thousands.

Summary
Total Assets164
Total Liabilities2,522
Total Stockholder Equity-2,359
 As reported
Total Liabilities 2,522
Total Stockholder Equity+ -2,359
Total Assets = 164

Assets

Total Assets164
Total Current Assets164
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 37
Total Current Assets  (as reported)164
Total Current Assets  (calculated)37
+/- 127
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,522
Long-term Liabilities0
Total Stockholder Equity-2,359
Total Current Liabilities
Short Long Term Debt 1,293
Accounts payable 231
Total Current Liabilities  (as reported)2,522
Total Current Liabilities  (calculated)1,524
+/- 998
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-2,359
Total Stockholder Equity (calculated)0
+/- 2,359
Other
Capital Stock3
Common Stock Shares Outstanding 31,111
Net Debt 1,255
Net Invested Capital -1,066
Net Working Capital -2,359



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-02-292023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-30
> Total Assets 
31
1
0
114
89
50
30
29
23
84
93
24
283
592
3,463
3,638
3,062
3,723
29
3,185
9,483
18,344
19,772
15,183
6,462
3,571
5,528
2,219
1,699
4,967
3,802
3,079
2,120
1,138
966
811
610
462
662
499
387
164
1643874996624626108119661,1382,1203,0793,8024,9671,6992,2195,5283,5716,46215,18319,77218,3449,4833,185293,7233,0623,6383,46359228324938423293050891140131
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
589
3,373
3,517
2,942
2,978
21
1,621
7,238
5,942
5,204
4,307
3,041
2,302
1,589
930
353
1,505
2,127
1,591
965
400
234
198
100
109
349
224
151
164
1641512243491091001982344009651,5912,1271,5053539301,5892,3023,0414,3075,2045,9427,2381,621212,9782,9423,5173,3735890000000000000
       Cash And Cash Equivalents 
31
1
0
99
66
8
22
26
10
77
89
19
278
567
3,190
3,367
2,888
2,864
20
1,394
6,580
5,168
494
266
319
587
358
778
184
1,334
1,968
1,386
786
232
96
118
22
48
44
130
82
37
3782130444822118962327861,3861,9681,3341847783585873192664945,1686,5801,394202,8642,8883,3673,190567278198977102622866990131
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,855
3,256
2,490
1,516
1,077
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,0771,5162,4903,2563,8550000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
500
500
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000050050050050000000000000000000000
       Other Current Assets 
0
0
0
14
18
37
4
0
10
5
2
3
4
22
183
150
54
114
0
0
0
500
500
500
0
0
0
0
0
0
0
0
0
168
138
0
78
61
305
0
69
0
069030561780138168000000000500500500000114541501832243251004371814000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,568
10,876
3,421
1,269
3,939
1,289
1,346
3,462
1,675
1,488
1,156
738
732
613
510
353
313
275
236
0
02362753133535106137327381,1561,4881,6753,4621,3461,2893,9391,2693,42110,87614,5680000000000000000000000
       Property Plant Equipment 
0
0
0
1
5
5
4
3
3
2
2
2
1
3
90
121
120
745
8
974
1,004
994
1,018
1,002
961
913
911
863
806
750
694
643
592
541
492
437
394
353
313
275
236
0
02362753133533944374925415926436947508068639119139611,0021,0189941,00497487451201219031222334551000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
590
1,023
7,325
9,222
6,011
2,460
356
3,028
427
540
2,712
981
845
564
197
239
176
116
0
0
0
0
0
000001161762391975648459812,7125404273,0283562,4606,0119,2227,3251,0235900000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,082
4,327
3,863
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,8634,3274,082000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
218
4,082
4,327
3,863
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,8634,3274,08221800000000000000000000
> Total Liabilities 
50
51
4
74
79
97
203
339
342
482
492
491
513
770
586
699
640
475
5
539
413
376
454
439
440
420
430
455
443
1,184
1,470
1,273
1,493
1,786
2,148
2,443
2,584
2,474
2,571
2,516
2,482
2,522
2,5222,4822,5162,5712,4742,5842,4432,1481,7861,4931,2731,4701,184443455430420440439454376413539547564069958677051349149248234233920397797445150
   > Total Current Liabilities 
50
51
4
74
79
97
203
339
342
482
492
491
513
770
586
699
640
475
5
539
413
376
454
439
440
420
430
455
443
1,184
1,470
1,273
1,493
1,786
2,148
2,443
2,584
2,474
2,571
2,516
2,482
2,522
2,5222,4822,5162,5712,4742,5842,4432,1481,7861,4931,2731,4701,184443455430420440439454376413539547564069958677051349149248234233920397797445150
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
284
59
66
66
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000006666592840000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
284
59
66
66
0
0
0
0
0
0
0
0
0
0
0
0
767
1,053
872
1,069
1,325
1,605
1,759
1,763
1,539
1,333
1,344
1,314
1,293
1,2931,3141,3441,3331,5391,7631,7591,6051,3251,0698721,0537670000000000006666592840000000000000
       Accounts payable 
24
11
4
25
23
12
19
114
114
243
215
266
226
240
282
387
350
251
3
316
189
153
230
215
217
196
206
231
219
193
193
178
200
237
320
461
597
711
1,015
336
246
231
2312463361,01571159746132023720017819319321923120619621721523015318931632513503872822402262662152431141141912232541124
       Other Current Liabilities 
26
40
0
49
56
85
184
225
225
225
277
225
265
530
304
312
290
224
2
224
224
0
224
224
224
224
224
224
224
224
224
224
224
224
224
224
224
0
224
0
0
0
00022402242242242242242242242242242242242242242242240224224222429031230453026522527722522522518485564904026
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
40
10
0
0
0
0
0
0
0
0
-178
2,877
2,939
2,422
3,248
24
2,646
9,071
17,968
19,318
14,744
6,021
3,151
5,098
1,765
1,256
3,783
2,332
1,806
627
-648
-1,182
-1,632
-1,974
-2,012
-1,909
-2,017
-2,095
-2,359
-2,359-2,095-2,017-1,909-2,012-1,974-1,632-1,182-6486271,8062,3323,7831,2561,7655,0983,1516,02114,74419,31817,9689,0712,646243,2482,4222,9392,877-178000000001040000
   Retained Earnings -24,763-24,438-24,259-23,686-23,531-20,907-20,549-20,069-19,388-18,149-16,826-16,145-14,821-14,286-13,631-12,900-12,174-11,306-6,164-4,771-4,223-7,953-7,297-60-5,693-4,058-3,520-2,417-2,1720000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-08-31)

Gross Profit (+$)
totalRevenue410
Cost of Revenue-0
Gross Profit0410
 
Operating Income (+$)
Gross Profit0
Operating Expense-1,342
Operating Income-931-1,342
 
Operating Expense (+$)
Research Development432
Selling General Administrative910
Selling And Marketing Expenses0
Operating Expense1,3421,342
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1
Other Finance Cost-0
Net Interest Income-1
 
Pretax Income (+$)
Operating Income-931
Net Interest Income-1
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,7101,846
EBIT - interestExpense = -1
-3,710
-3,709
Interest Expense1
Earnings Before Interest and Taxes (EBIT)0-3,709
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,710
Tax Provision-0
Net Income From Continuing Ops-3,710-3,710
Net Income-3,710
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-2,7781
 

Technical Analysis of Cannabics Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cannabics Pharmaceuticals Inc. The general trend of Cannabics Pharmaceuticals Inc is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cannabics Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cannabics Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.02 < 0.02 < 0.02.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Cannabics Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cannabics Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cannabics Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cannabics Pharmaceuticals Inc. The current macd is -0.00021035.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cannabics Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cannabics Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cannabics Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cannabics Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartCannabics Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cannabics Pharmaceuticals Inc. The current adx is 72.46.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cannabics Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Cannabics Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cannabics Pharmaceuticals Inc. The current sar is 0.01817073.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cannabics Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cannabics Pharmaceuticals Inc. The current rsi is 54.20. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Cannabics Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartCannabics Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cannabics Pharmaceuticals Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cannabics Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cannabics Pharmaceuticals Inc Daily Stochastic Oscillator ChartCannabics Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cannabics Pharmaceuticals Inc. The current cci is 28.57.

Cannabics Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartCannabics Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cannabics Pharmaceuticals Inc. The current cmo is 21.44.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cannabics Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartCannabics Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cannabics Pharmaceuticals Inc. The current willr is -70.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cannabics Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cannabics Pharmaceuticals Inc Daily Williams %R ChartCannabics Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cannabics Pharmaceuticals Inc. The current atr is 0.00292388.

Cannabics Pharmaceuticals Inc Daily Average True Range (ATR) ChartCannabics Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cannabics Pharmaceuticals Inc. The current obv is 6,339,466.

Cannabics Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartCannabics Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cannabics Pharmaceuticals Inc. The current mfi is 94.56.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Cannabics Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartCannabics Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cannabics Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Cannabics Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cannabics Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.204
Ma 20Greater thanMa 500.011
Ma 50Greater thanMa 1000.012
Ma 100Greater thanMa 2000.013
OpenGreater thanClose0.013
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cannabics Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Cannabics Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cannabics Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cannabics Pharmaceuticals Inc

I send you an email if I find something interesting about Cannabics Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cannabics Pharmaceuticals Inc.

Receive notifications about Cannabics Pharmaceuticals Inc in your mailbox!